skip to main content

We represent and defend clients across the full spectrum of the pharmaceutical industry, including research and development companies, mainline pharmaceutical manufacturers, generic manufacturers; pharmacy benefit managers (PBM); and retail and hospital-based pharmacies.

News & Insights

Overview Attorneys

Insights

News Media & Articles Speaking Engagements Blogs and Thought Leadership

Re-Opened for Litigation: Examining Potential for COVID-19 Third Party Exposure Claims Against Businesses and How to Mitigate and Defend Them

OSHA Issues Guidance to Employers on COVID-19

Post & Schell, P.C.'s Paycheck Protection Program Loan Forgiveness Tool

DOL to Begin Enforcement of FFCRA Paid Leave Obligations; Issues Additional FAQs

Pennsylvania Amends its Unemployment Law in Response to COVID-19

Employment Taxes During the COVID-19 Pandemic

DOL Issues Much Anticipated Regs and IRS Issues Guidance on Families First Coronavirus Response Act

Workers' Compensation Injuries, Employees Working from Home, and the COVID-19 Shutdown

Caution Urged with the PA WC Bureau's New EDI Recommendations for COVID-19 Claims

DOL Issues Third Round of Guidance on Families First Coronavirus Response Act

DOL Issues Second Round of Guidance on Families First Coronavirus Response Act

DOL Issues Initial Guidance on Families First Coronavirus Response Act and Publishes Required Model Notice

Employment Tax Aspects of the Coronavirus Response Act

Workers' Compensation Rights/ Obligations in Light of the Forced Government Shutdown Due to COVID-19

EEOC Issues New Guidance for Managing COVID-19 Risks Consistent with the ADA

President Signs Bill Requiring Employers to Provide Paid Leave to Employees Affected by the Coronavirus/COVID-19

House Amends Bill Requiring Employers to Provide Paid Leave to Employees Affected by the Coronavirus/COVID-19

U.S. House Passes Bill Requiring Employers to Provide Paid Leave to Employees Affected by the Coronavirus/COVID-19

New Jersey Employers Face Continued Difficulty Enforcing Employee Arbitration Agreements

Opioid Law Creates Addiction-Treatment Kickback Crime That Reaches Commercial Health Insurance

Eastern District of Pennsylvania Refuses to Keep FCA Qui Tam Complaint Under Seal to Facilitate Government's Settlement Negotiations

OIG 15-Year Exclusion for False Claims Act Violations by Lab Company and its CEO Sends Warning to FCA Defendants

Eastern District of Pennsylvania Forms Civil Enforcement Strike Force Adding Resources to False Claims Act Cases

Pennsylvania Supreme Court: Unfair Trade Practices and Consumer Protection Law Applies to Out-of-State Residents

Steps Employers Can Take to Prevent and Respond to Claims of Sexual Harassment

Third Circuit Rejects FCA Claims of Medicare Part D Fraud Applying Post-Escobar Materiality Bar; Acknowledges Validity of Government Knowledge Inference Defense

Pennsylvania Imposes New Withholding Requirements on Businesses

DOH Issues Temporary Regulations for Patients and Caregivers

DOH Issues Medical Marijuana Practitioner Rules

Off Label-Marketing and Free Speech: Report from APhA 2017 Annual Meeting

Government Contests Assertion of Attorney-Client Privilege in Assessing Cooperation

DOH Issues Temporary Regulations for Medical Marijuana Dispensaries

DEP Issues New Stormwater General Permit Requirements for Industrial Activity

Pennsylvania's Medical Marijuana Law, Health Care Providers, and Enforcement

The Enforceability of FDA's Off-Label Marketing Restrictions Following the Amarin Decision

HHS-OIG Senior Counsel Riordan Focuses on Kickbacks, Accountability, and the Role of Compliance in Pharma Compliance Congress Keynote

PharMerica Settlements Highlight Potential for Dual False Claims Act and Controlled Substances Act Liability for Invalid Prescriptions

Pennsylvania Supreme Court's Decision in Tincher v. Omega Flex, Inc. Leaves the State of Products Liability Litigation Up in the Air

Third Circuit Decision Adopts More Lenient Pleading Standard in False Claims Act Litigation

Third Circuit Decision Adopts More Lenient Pleading Standard in False Claims Act Litigation